According to DataM Intelligence, "The RNA-Based Therapies Market Size, valued at USD 90.56 billion in 2024, is projected to ...

In a Q&A with STAT, Nobel winner Drew Weissman addressed concerns raised about Covid shots at a recent meeting of federal ...

Scientists hope genetically modified mice will curb the spread of Lyme disease. They headed to Nantucket — home to a large ...

In a chaotic meeting, ACIP voted not to recommend a prescription requirement for Covid-19 vaccines. Some panelists seemed ...

After an unusual meeting, the CDC's Advisory Committee on Immunization Practices has issued new recommendations about this year's updated COVID-19 vaccines. Here's what to know.

In this Daily Rip Live clip, Shay Boloor tells Jordan why he’s excited about biotech and CRISPR names in his small-cap portfolio. 🧬 Shay owns Intellia ($NTLA), Beam ($BEAM), and Prime ($PRME), and ...

After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...

From breakthroughs in artificial intelligence to revolutionary discoveries in medicine, the forces shaping tomorrow are being ...

Moderna (MRNA) and Alnylam (ALNY) resolve a patent dispute related to the technology used in former's COVID-19 vaccine. Read ...

The vaccine advisory group ACIP, not all members of which seemed to know what the group does, recommended to the CDC that combined MMRV shots not be given before age 4.

Moderna has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' patented technology in its COVID-19 ...